Opioid Endocrinopathy
The use of prescription opioids has increased dramatically over the past 20 years. Opioids appear to affect multiple endocrine pathways leading to abnormal levels of different hormones such as testosterone, cortisol, and prolactin (PRL). In this article, we review the current data regarding opioid e...
Saved in:
| Published in | Endocrine practice Vol. 21; no. 2; pp. 190 - 199 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Elsevier Limited
01.02.2015
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The use of prescription opioids has increased dramatically over the past 20 years. Opioids appear to affect multiple endocrine pathways leading to abnormal levels of different hormones such as testosterone, cortisol, and prolactin (PRL). In this article, we review the current data regarding opioid effects on the hypothalamus, pituitary, and bone metabolism.
We conducted a PubMed search for articles regarding opioids and each of the following subjects: testosterone, estrogen, cortisol, thyroid, growth hormone (GH), and bone. Most articles were primary source studies conducted between 1980 and 2014. Articles were included if studies were conducted within the time period, published in English, and available as full-length articles. Case reports were reviewed, but controlled studies were given more weight.
Opioids appear to affect each of the pituitary hormone pathways in addition to altering bone metabolism. The most commonly reported and substantial effect was hypogonadism in both sexes; however, suppression of the adrenal axis may be more common than initially thought. Although some studies report a change in thyroid and GH levels, overall effects have not been thoroughly studied. There is some evidence for increased fracture risk, possibly mediated by hypogonadism and fall risk.
More research is needed to determine which opioids are more likely to cause endocrine dysfunction and which patients need to be screened and treated. Also unknown is the length of time to the development of hormonal changes after starting opioid therapy and if cessation of opioid therapy can normalize hormone levels. |
|---|---|
| AbstractList | The use of prescription opioids has increased dramatically over the past 20 years. Opioids appear to affect multiple endocrine pathways leading to abnormal levels of different hormones such as testosterone, cortisol, and prolactin (PRL). In this article, we review the current data regarding opioid effects on the hypothalamus, pituitary, and bone metabolism.
We conducted a PubMed search for articles regarding opioids and each of the following subjects: testosterone, estrogen, cortisol, thyroid, growth hormone (GH), and bone. Most articles were primary source studies conducted between 1980 and 2014. Articles were included if studies were conducted within the time period, published in English, and available as full-length articles. Case reports were reviewed, but controlled studies were given more weight.
Opioids appear to affect each of the pituitary hormone pathways in addition to altering bone metabolism. The most commonly reported and substantial effect was hypogonadism in both sexes; however, suppression of the adrenal axis may be more common than initially thought. Although some studies report a change in thyroid and GH levels, overall effects have not been thoroughly studied. There is some evidence for increased fracture risk, possibly mediated by hypogonadism and fall risk.
More research is needed to determine which opioids are more likely to cause endocrine dysfunction and which patients need to be screened and treated. Also unknown is the length of time to the development of hormonal changes after starting opioid therapy and if cessation of opioid therapy can normalize hormone levels. In this article, we review the current data regarding opioid effects on the hypothalamus, pituitary, and bone metabolism. The authors conducted a PubMed search for articles regarding opioids and each of the following subjects: testosterone, estrogen, cortisol, thyroid, growth hormone (GH), and bone. Most articles were primary source studies conducted between 1980 and 2014. Articles were included if studies were conducted within the time period, published in English, and available as full-length articles. Case reports were reviewed, but controlled studies were given more weight. Opioids appear to affect each of the pituitary hormone pathways in addition to altering bone metabolism. The most commonly reported and substantial effect was hypogonadism in both sexes; however, suppression of the adrenal axis may be more common than initially thought. Although some studies report a change in thyroid and GH levels, overall effects have not been thoroughly studied. There is some evidence for increased fracture risk, possibly mediated by hypogonadism and fall risk. The use of prescription opioids has increased dramatically over the past 20 years. Opioids appear to affect multiple endocrine pathways leading to abnormal levels of different hormones such as testosterone, cortisol, and prolactin (PRL). In this article, we review the current data regarding opioid effects on the hypothalamus, pituitary, and bone metabolism.OBJECTIVEThe use of prescription opioids has increased dramatically over the past 20 years. Opioids appear to affect multiple endocrine pathways leading to abnormal levels of different hormones such as testosterone, cortisol, and prolactin (PRL). In this article, we review the current data regarding opioid effects on the hypothalamus, pituitary, and bone metabolism.We conducted a PubMed search for articles regarding opioids and each of the following subjects: testosterone, estrogen, cortisol, thyroid, growth hormone (GH), and bone. Most articles were primary source studies conducted between 1980 and 2014. Articles were included if studies were conducted within the time period, published in English, and available as full-length articles. Case reports were reviewed, but controlled studies were given more weight.METHODSWe conducted a PubMed search for articles regarding opioids and each of the following subjects: testosterone, estrogen, cortisol, thyroid, growth hormone (GH), and bone. Most articles were primary source studies conducted between 1980 and 2014. Articles were included if studies were conducted within the time period, published in English, and available as full-length articles. Case reports were reviewed, but controlled studies were given more weight.Opioids appear to affect each of the pituitary hormone pathways in addition to altering bone metabolism. The most commonly reported and substantial effect was hypogonadism in both sexes; however, suppression of the adrenal axis may be more common than initially thought. Although some studies report a change in thyroid and GH levels, overall effects have not been thoroughly studied. There is some evidence for increased fracture risk, possibly mediated by hypogonadism and fall risk.RESULTSOpioids appear to affect each of the pituitary hormone pathways in addition to altering bone metabolism. The most commonly reported and substantial effect was hypogonadism in both sexes; however, suppression of the adrenal axis may be more common than initially thought. Although some studies report a change in thyroid and GH levels, overall effects have not been thoroughly studied. There is some evidence for increased fracture risk, possibly mediated by hypogonadism and fall risk.More research is needed to determine which opioids are more likely to cause endocrine dysfunction and which patients need to be screened and treated. Also unknown is the length of time to the development of hormonal changes after starting opioid therapy and if cessation of opioid therapy can normalize hormone levels.CONCLUSIONMore research is needed to determine which opioids are more likely to cause endocrine dysfunction and which patients need to be screened and treated. Also unknown is the length of time to the development of hormonal changes after starting opioid therapy and if cessation of opioid therapy can normalize hormone levels. |
| Author | Demarest, Susan P. Adler, Robert A. Gill, Ranjodh S. |
| Author_xml | – sequence: 1 givenname: Susan P. surname: Demarest fullname: Demarest, Susan P. – sequence: 2 givenname: Ranjodh S. surname: Gill fullname: Gill, Ranjodh S. – sequence: 3 givenname: Robert A. surname: Adler fullname: Adler, Robert A. |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25536970$$D View this record in MEDLINE/PubMed |
| BookMark | eNpt0EtLAzEQB_AgFfvQi-BVBC8ibM1jk02OpdQHFCpFwVvIZrOYsk3WZPfQb2-k1UPxNHP4_YeZGYOB884AcIngNEeUPyxeUU6ImK5nJ2CEBMkznEMySD0lMOMCfQzBOMYNhBgKxM_AEFNKmCjgCFytWuttdbNwldfBOt-q7nN3Dk5r1URzcagT8P64eJs_Z8vV08t8tsw0yVGXqYqpmlcGF5ARYhQuCooJQxgWtYaIs9SwshRKGFyihLSpRUlpzQVVBVdkAu72c9vgv3oTO7m1UZumUc74PkrEKE8xJGCit0d04_vg0nZJMUQwztNRE3B9UH25NZVsg92qsJO_Bydwvwc6-BiDqf8IgvLnm_LwTbmeJQyPsLad6qx3XVC2-S_yDSdYcsA |
| CitedBy_id | crossref_primary_10_1002_art_39422 crossref_primary_10_1002_hup_2908 crossref_primary_10_1097_j_pain_0000000000000637 crossref_primary_10_4158_EP14584_CO crossref_primary_10_1016_j_sxmr_2015_10_014 crossref_primary_10_1007_s40265_019_01236_4 crossref_primary_10_5812_aapm_119156 crossref_primary_10_3233_NRE_208005 crossref_primary_10_1016_j_arth_2019_08_003 crossref_primary_10_3389_fnint_2018_00042 crossref_primary_10_1007_s11154_024_09877_x crossref_primary_10_1111_1440_1681_13246 crossref_primary_10_1002_ejp_1247 crossref_primary_10_1016_j_explore_2018_02_001 crossref_primary_10_1016_j_intimp_2021_107714 crossref_primary_10_1016_j_jsxm_2017_12_004 crossref_primary_10_1177_0310057X211018211 crossref_primary_10_1177_2049463717734016 crossref_primary_10_4103_psychiatry_IndianJPsychiatry_195_19 crossref_primary_10_1007_s40267_020_00756_4 crossref_primary_10_1007_s40619_015_0127_0 crossref_primary_10_1111_papr_12731 |
| Cites_doi | 10.1210/er.2009-0009 10.1016/j.bone.2011.11.014 10.1210/jcem-69-2-356 10.1097/00044067-200507000-00003 10.1016/S0140-6736(82)92830-6 10.1055/s-2005-870230 10.1159/000123558 10.1007/s11606-009-1218-z 10.1016/j.psyneuen.2009.05.013 10.1002/cncr.22933 10.1111/j.1360-0443.2010.03159.x 10.1097/AJP.0b013e3181d1059d 10.1111/j.1464-410X.2012.10968.x 10.1159/000346110 10.1007/s00228-011-0992-9 10.2174/138161212803582414 10.36076/ppj.2012/15/ES9 10.1097/00002508-200205000-00002 10.1517/13543780903405608 10.1038/sj.npp.1300856 10.1159/000054586 10.1080/13556210500351263 10.1159/000124091 10.1097/00002508-200009000-00011 10.1016/j.suponc.2012.05.002 10.1054/jpai.2002.126790 10.1001/archinternmed.2010.391 10.1210/jc.2006-0599 10.1002/14651858.CD006605.pub2 10.1210/jc.2004-0929 10.1186/1477-7827-9-26 10.1210/jcem-65-2-295 10.1111/j.1365-2265.2007.02779.x 10.1016/j.jpain.2007.08.005 10.1016/j.amjmed.2005.07.033 10.1176/ajp.137.7.862 10.1210/jc.2009-2354 10.1001/archinte.163.8.949 10.1111/j.1365-2796.2005.01483.x 10.1055/s-0029-1202851 10.1111/j.1526-4637.2012.01368.x 10.1300/J069v21n04_05 10.1186/1744-8069-6-69 10.1210/jcem-60-5-891 10.2174/138161212803582487 10.1592/phco.22.13.1188.33526 10.1001/jama.284.4.423b 10.1016/j.jpain.2006.04.011 10.1111/j.1743-6109.2009.01454.x 10.1530/eje.0.1370631 10.1210/jcem.85.6.6615 10.1530/EJE-13-0321 |
| ContentType | Journal Article |
| Copyright | Copyright Allen Press Publishing Services Feb 2015 |
| Copyright_xml | – notice: Copyright Allen Press Publishing Services Feb 2015 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7X7 7XB 88C 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU FYUFA GHDGH K9- K9. KB0 M0R M0S M0T M1P NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 |
| DOI | 10.4158/EP14339.RA |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Healthcare Administration Database (Alumni) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) Consumer Health Database (Alumni Edition) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Consumer Health Database ProQuest Health & Medical Collection Healthcare Administration Database Medical Database Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Family Health (Alumni Edition) ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Health Management ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Health Management (Alumni Edition) ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE ProQuest One Academic Middle East (New) MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1934-2403 |
| EndPage | 199 |
| ExternalDocumentID | 3617879741 25536970 10_4158_EP14339_RA |
| Genre | Journal Article Review Feature |
| GroupedDBID | --- 0R~ 4.4 53G 5GY 7RV 7X7 88E 8FI 8FJ AALRI AAQQT AAXUO AAYXX ABJNI ABUWG ADBBV AENEX AFJKZ AFKRA AGCQF AHMBA AITUG ALIPV ALMA_UNASSIGNED_HOLDINGS AMRAJ APXCP AQUVI AZQEC BENPR BKEYQ BKNYI BPHCQ BVXVI CCPQU CITATION EBS EJD F5P FDB FYUFA HMCUK K9- M0R M0T M1P MAS MCE MET NAPCQ OVD P2P PHGZM PHGZT PQQKQ PROAC PSQYO ROL TEORI UKHRP CGR CUY CVF ECM EFKBS EIF NPM PJZUB PPXIY 3V. 7XB 8FK K9. PKEHL PQEST PQUKI PRINS 7X8 |
| ID | FETCH-LOGICAL-c341t-ad6af8de270633ea27752361207fc01862076bb9a9e2b1706cef9b55f895a78a3 |
| IEDL.DBID | 7X7 |
| ISSN | 1530-891X |
| IngestDate | Tue Aug 05 10:43:32 EDT 2025 Fri Jul 25 04:12:03 EDT 2025 Mon Jul 21 06:08:35 EDT 2025 Tue Jul 01 02:55:08 EDT 2025 Thu Apr 24 23:00:18 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Language | English |
| License | https://www.elsevier.com/tdm/userlicense/1.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c341t-ad6af8de270633ea27752361207fc01862076bb9a9e2b1706cef9b55f895a78a3 |
| Notes | SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| PMID | 25536970 |
| PQID | 1661322455 |
| PQPubID | 1896353 |
| PageCount | 10 |
| ParticipantIDs | proquest_miscellaneous_1658706190 proquest_journals_1661322455 pubmed_primary_25536970 crossref_primary_10_4158_EP14339_RA crossref_citationtrail_10_4158_EP14339_RA |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2015-02-01 |
| PublicationDateYYYYMMDD | 2015-02-01 |
| PublicationDate_xml | – month: 02 year: 2015 text: 2015-02-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: Jacksonville |
| PublicationTitle | Endocrine practice |
| PublicationTitleAlternate | Endocr Pract |
| PublicationYear | 2015 |
| Publisher | Elsevier Limited |
| Publisher_xml | – name: Elsevier Limited |
| References | Kokko (10.4158/EP14339.RA_bb0235) 2002; 22 Blick (10.4158/EP14339.RA_bb0050) 2012; 13 Oltmanns (10.4158/EP14339.RA_bb0170) 2005; 257 Dackis (10.4158/EP14339.RA_bb0150) 1982; 2 Moshtaghi-Kashanian (10.4158/EP14339.RA_bb0225) 2005; 10 Manchikanti (10.4158/EP14339.RA_bb0005) 2012; 15 Davis (10.4158/EP14339.RA_bb0100) 2012; 10 Mattia (10.4158/EP14339.RA_bb0260) 2012 Perez-Castrillón (10.4158/EP14339.RA_bb0270) 2000; 72 Noble (10.4158/EP14339.RA_bb0015) 2010 Raff (10.4158/EP14339.RA_bb0160) 1987; 65 Mussig (10.4158/EP14339.RA_bb0185) 2007; 66 Finch (10.4158/EP14339.RA_bb0265) 2014 Nelson (10.4158/EP14339.RA_bb0250) 2012; 50 Saunders (10.4158/EP14339.RA_bb0255) 2010 Phillips (10.4158/EP14339.RA_bb0010) 2000; 284 Kinjo (10.4158/EP14339.RA_bb0245) 2005; 118 Ensrud (10.4158/EP14339.RA_bb0240) 2003; 163 Bliesener (10.4158/EP14339.RA_bb0105) 2005; 90 Schimke (10.4158/EP14339.RA_bb0175) 2009; 117 Samuels (10.4158/EP14339.RA_bb0220) 1994; 78 Rhodin (10.4158/EP14339.RA_bb0020) 2010; 26 Rittmaster (10.4158/EP14339.RA_bb0155) 1985; 60 Holden (10.4158/EP14339.RA_bb0030) 2005; 16 Abs (10.4158/EP14339.RA_bb0065) 2000; 85 Aloisi (10.4158/EP14339.RA_bb0125) 2011; 9 Aloisi (10.4158/EP14339.RA_bb0195) 2009; 34S Taylor (10.4158/EP14339.RA_bb0140) 2010; 7 Bhasin (10.4158/EP14339.RA_bb0120) 2010; 95 Saigal (10.4158/EP14339.RA_bb0110) 2007; 110 Delitala (10.4158/EP14339.RA_bb0210) 1989; 69 Devilla (10.4158/EP14339.RA_bb0215) 1985; 40 Bhansali (10.4158/EP14339.RA_bb0200) 2005; 37 Villa (10.4158/EP14339.RA_bb0205) 1997; 137 Moskovic (10.4158/EP14339.RA_bb0130) 2012; 110 Kaminetsky (10.4158/EP14339.RA_bb0135) 2009; 18 Debono (10.4158/EP14339.RA_bb0180) 2011; 67 Finch (10.4158/EP14339.RA_bb0070) 2000; 16 Vuong (10.4158/EP14339.RA_bb0035) 2010; 31 Aloisi (10.4158/EP14339.RA_bb0055) 2010; 6 Daniell (10.4158/EP14339.RA_bb0165) 2006; 7 Roberts (10.4158/EP14339.RA_bb0095) 2002; 18 Agirregoitia (10.4158/EP14339.RA_bb0060) 2006; 91 Chong (10.4158/EP14339.RA_bb0190) 2006; 31 Elliott (10.4158/EP14339.RA_bb0040) 2012; 18 Daniell (10.4158/EP14339.RA_bb0090) 2008; 9 Gold (10.4158/EP14339.RA_bb0145) 1980; 137 Grey (10.4158/EP14339.RA_bb0080) 2011; 106 Daniell (10.4158/EP14339.RA_bb0075) 2002; 3 Glahn (10.4158/EP14339.RA_bb0230) 2013; 67 Muraleedharan (10.4158/EP14339.RA_bb0115) 2013; 169 Delitala (10.4158/EP14339.RA_bb0045) 1983; 37 Solomon (10.4158/EP14339.RA_bb0025) 2010; 170 Daniell (10.4158/EP14339.RA_bb0085) 2002; 21 Endocr Pract. 2015 May;21(5):559 25716638 - Endocr Pract. 2015 Apr;21(4):450-1 |
| References_xml | – volume: 31 start-page: 98 year: 2010 ident: 10.4158/EP14339.RA_bb0035 article-title: The effects of opioids and opioid analogs on animal and human endocrine systems publication-title: Endo Rev. doi: 10.1210/er.2009-0009 – volume: 50 start-page: 983 year: 2012 ident: 10.4158/EP14339.RA_bb0250 article-title: Factors associated with screening or treatment initiation among male United States veterans at risk for osteoporosis fracture publication-title: Bone. doi: 10.1016/j.bone.2011.11.014 – volume: 69 start-page: 356 year: 1989 ident: 10.4158/EP14339.RA_bb0210 article-title: Opioids stimulate growth hormone (GH) release in man independently of GH-releasing hormone publication-title: J Clin Endocrinol Metab. doi: 10.1210/jcem-69-2-356 – volume: 16 start-page: 291 year: 2005 ident: 10.4158/EP14339.RA_bb0030 article-title: The endogenous opioid system and clinical pain management publication-title: AACN Clin Issues. doi: 10.1097/00044067-200507000-00003 – volume: 2 start-page: 1167 year: 1982 ident: 10.4158/EP14339.RA_bb0150 article-title: Methadone induced hypoadrenalism publication-title: Lancet. doi: 10.1016/S0140-6736(82)92830-6 – volume: 37 start-page: 425 year: 2005 ident: 10.4158/EP14339.RA_bb0200 article-title: Effect of opiates on growth hormone secretion in acromegaly publication-title: Horm Metab Res. doi: 10.1055/s-2005-870230 – volume: 37 start-page: 275 year: 1983 ident: 10.4158/EP14339.RA_bb0045 article-title: Differential effects of opioid peptides and alkaloids on anterior pituitary hormone secretion publication-title: Neuroendocrinology. doi: 10.1159/000123558 – start-page: 310 year: 2010 ident: 10.4158/EP14339.RA_bb0255 article-title: Relationship of opioid use and dosage levels to fractures in older chronic pain patients publication-title: J Gen Intern Med. doi: 10.1007/s11606-009-1218-z – volume: 34S start-page: S162 year: 2009 ident: 10.4158/EP14339.RA_bb0195 article-title: Endocrine consequences of opioid therapy publication-title: Psychoneuroendocrinology. doi: 10.1016/j.psyneuen.2009.05.013 – volume: 110 start-page: 1493 year: 2007 ident: 10.4158/EP14339.RA_bb0110 article-title: Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer publication-title: Cancer. doi: 10.1002/cncr.22933 – volume: 106 start-page: 349 year: 2011 ident: 10.4158/EP14339.RA_bb0080 article-title: Decreased bone density in men on methadone maintenance therapy publication-title: Addiction. doi: 10.1111/j.1360-0443.2010.03159.x – volume: 26 start-page: 374 year: 2010 ident: 10.4158/EP14339.RA_bb0020 article-title: Opioid endocrinopathy: a clinical problem in patients with chronic pain and long-term oral opioid treatment publication-title: Clin J Pain. doi: 10.1097/AJP.0b013e3181d1059d – volume: 110 start-page: 1524 year: 2012 ident: 10.4158/EP14339.RA_bb0130 article-title: Clomiphene citrate is safe and effective for long-term management of hypogonadism publication-title: BJU Int. doi: 10.1111/j.1464-410X.2012.10968.x – volume: 67 start-page: 111 year: 2013 ident: 10.4158/EP14339.RA_bb0230 article-title: Atrial natriuretic peptide, arginine vasopressin peptide and cortisol serum levels in opiate-dependent patients publication-title: Neuropsychobiology. doi: 10.1159/000346110 – volume: 67 start-page: 865 year: 2011 ident: 10.4158/EP14339.RA_bb0180 article-title: Tramadol-induced adrenal insufficiency publication-title: Eur J Clin Pharmacol. doi: 10.1007/s00228-011-0992-9 – volume: 18 start-page: 6070 year: 2012 ident: 10.4158/EP14339.RA_bb0040 article-title: Non-analgesic effects of opioids: opioids and the endocrine system publication-title: Curr Pharm Des. doi: 10.2174/138161212803582414 – volume: 15 start-page: ES9 year: 2012 ident: 10.4158/EP14339.RA_bb0005 article-title: Opioid epidemic in the United States publication-title: Pain Phys. doi: 10.36076/ppj.2012/15/ES9 – volume: 18 start-page: 144 year: 2002 ident: 10.4158/EP14339.RA_bb0095 article-title: Sex hormone suppression by intrathecal opioids: a prospective study publication-title: Clin J Pain. doi: 10.1097/00002508-200205000-00002 – volume: 18 start-page: 1947 year: 2009 ident: 10.4158/EP14339.RA_bb0135 article-title: Clomiphene citrate and enclomiphene for the treatment of hypogonadal androgen deficiency publication-title: Expert Opin Investig Drugs. doi: 10.1517/13543780903405608 – volume: 31 start-page: 204 year: 2006 ident: 10.4158/EP14339.RA_bb0190 article-title: The mu-opioid receptor polymorphism A118G predicts cortisol responses to naloxone and stress publication-title: Neuropsychopharmacology. doi: 10.1038/sj.npp.1300856 – volume: 72 start-page: 187 year: 2000 ident: 10.4158/EP14339.RA_bb0270 article-title: Expression of opioid receptors in osteoblast-like MG-63 cells and effects of different opioid agonists on alkaline phosphatase and osteocalcin secretion by these cells publication-title: Neuroendocrinology. doi: 10.1159/000054586 – volume: 10 start-page: 345 year: 2005 ident: 10.4158/EP14339.RA_bb0225 article-title: Enhanced prolactin levels in opium smokers publication-title: Addict Biol. doi: 10.1080/13556210500351263 – volume: 40 start-page: 303 year: 1985 ident: 10.4158/EP14339.RA_bb0215 article-title: Morphine-induced TSH release in normal and hypothyroid subjects publication-title: Neuroendocrinology. doi: 10.1159/000124091 – volume: 16 start-page: 251 year: 2000 ident: 10.4158/EP14339.RA_bb0070 article-title: Hypogonadism in patients treated with intrathecal morphine publication-title: Clin J Pain. doi: 10.1097/00002508-200009000-00011 – volume: 10 start-page: 209 year: 2012 ident: 10.4158/EP14339.RA_bb0100 article-title: Twelve reasons for considering buprenorphine as a frontline analgesic in the management of pain publication-title: J Support Oncol. doi: 10.1016/j.suponc.2012.05.002 – volume: 78 start-page: 1249 year: 1994 ident: 10.4158/EP14339.RA_bb0220 article-title: Effects of naloxone infusion on pulsatile thyrotropin secretion publication-title: J Clin Endocrinol Metab. – volume: 3 start-page: 377 year: 2002 ident: 10.4158/EP14339.RA_bb0075 article-title: Hypogonadism in men consuming sustained-action oral opioids publication-title: J Pain. doi: 10.1054/jpai.2002.126790 – volume: 170 start-page: 1968 year: 2010 ident: 10.4158/EP14339.RA_bb0025 article-title: The comparative safety of analgesics in older adults with arthritis publication-title: Arch Intern Med. doi: 10.1001/archinternmed.2010.391 – volume: 91 start-page: 4969 year: 2006 ident: 10.4158/EP14339.RA_bb0060 article-title: Expression and localization of delta-, kappa-, and mu-opioid receptors in human spermatozoa and implications for sperm motility publication-title: J Clin Endocrinol Metab. doi: 10.1210/jc.2006-0599 – year: 2010 ident: 10.4158/EP14339.RA_bb0015 article-title: Long-term opioid management for chronic noncancer pain publication-title: Cochrane Database Syst Rev. doi: 10.1002/14651858.CD006605.pub2 – volume: 90 start-page: 203 year: 2005 ident: 10.4158/EP14339.RA_bb0105 article-title: Lichtermann, Klingmiiller D. Plasma testosterone and sexual function in men receiving buprenorphine maintenance for opioid dependence publication-title: J Clin Endocrinol Metab. doi: 10.1210/jc.2004-0929 – volume: 9 start-page: 26 year: 2011 ident: 10.4158/EP14339.RA_bb0125 article-title: Hormone replacement therapy in morphine-induced hypogonad-ic male chronic pain patients publication-title: Reprod Biol Endocrinol. doi: 10.1186/1477-7827-9-26 – volume: 65 start-page: 295 year: 1987 ident: 10.4158/EP14339.RA_bb0160 article-title: Inhibition of the adrenocorticotropin response to surgery in humans: Interaction between dexamethasone and fentanyl publication-title: J Clin Endocrinol Metab. doi: 10.1210/jcem-65-2-295 – volume: 66 start-page: 604 year: 2007 ident: 10.4158/EP14339.RA_bb0185 article-title: Secondary adrenal failure and secondary amenorrhea following hydromorphone treatment publication-title: Clin Endocrinol (Oxf). doi: 10.1111/j.1365-2265.2007.02779.x – volume: 9 start-page: 28 year: 2008 ident: 10.4158/EP14339.RA_bb0090 article-title: Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain publication-title: J Pain. doi: 10.1016/j.jpain.2007.08.005 – volume: 118 start-page: 1414 year: 2005 ident: 10.4158/EP14339.RA_bb0245 article-title: Bone mineral density in subjects using central nervous system-active medications publication-title: Am J Med. doi: 10.1016/j.amjmed.2005.07.033 – volume: 137 start-page: 862 year: 1980 ident: 10.4158/EP14339.RA_bb0145 article-title: Suppression of plasma cortisol in depressed patients by acute intravenous methadone infusion publication-title: Am J Psychiatry. doi: 10.1176/ajp.137.7.862 – volume: 95 start-page: 2536 year: 2010 ident: 10.4158/EP14339.RA_bb0120 article-title: Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline publication-title: J Clin Endocrinol Metab. doi: 10.1210/jc.2009-2354 – volume: 163 start-page: 949 year: 2003 ident: 10.4158/EP14339.RA_bb0240 article-title: Central nervous system active medications and risk for fractures in older women publication-title: Arch Intern Med. doi: 10.1001/archinte.163.8.949 – volume: 257 start-page: 478 year: 2005 ident: 10.4158/EP14339.RA_bb0170 article-title: Chronic fentanyl application induced adrenocortical insufficiency publication-title: J Intern Med. doi: 10.1111/j.1365-2796.2005.01483.x – volume: 117 start-page: 649 year: 2009 ident: 10.4158/EP14339.RA_bb0175 article-title: Secondary adrenal insufficiency due to opiate therapy - another differential diagnosis worth considering publication-title: Exp Clin Endocrinol Diabetes. doi: 10.1055/s-0029-1202851 – volume: 13 start-page: 688 year: 2012 ident: 10.4158/EP14339.RA_bb0050 article-title: Testosterone replacement therapy outcomes among opioid users: The Testim Registry in the United States (TRiUS) publication-title: Pain Med. doi: 10.1111/j.1526-4637.2012.01368.x – volume: 21 start-page: 47 year: 2002 ident: 10.4158/EP14339.RA_bb0085 article-title: Narcotic-induced hypogonadism during therapy for heroin addiction publication-title: J Addict Dis. doi: 10.1300/J069v21n04_05 – volume: 6 start-page: 1 year: 2010 ident: 10.4158/EP14339.RA_bb0055 article-title: Aromatase and 5-alpha reductase gene expression: modulation by pain and morphine treatment in male rats publication-title: Mol Pain. doi: 10.1186/1744-8069-6-69 – volume: 60 start-page: 891 year: 1985 ident: 10.4158/EP14339.RA_bb0155 article-title: Morphine inhibits the pituitary-adrenal response to ovine corticotropin-releasing hormone in normal subjects publication-title: J Clin Endocrinol Metab. doi: 10.1210/jcem-60-5-891 – start-page: 6005 year: 2012 ident: 10.4158/EP14339.RA_bb0260 article-title: Non-analgesic effects of opioids: the interaction of opioids with bone and joints publication-title: Curr Pharm Des. doi: 10.2174/138161212803582487 – volume: 22 start-page: 1188 year: 2002 ident: 10.4158/EP14339.RA_bb0235 article-title: Fentanyl-associated syndrome of inappropriate antidiuretic hormone secretion publication-title: Pharmacotherapy. doi: 10.1592/phco.22.13.1188.33526 – volume: 284 start-page: 428 year: 2000 ident: 10.4158/EP14339.RA_bb0010 article-title: JCAHO pain management standards are unveiled. Joint Commission on Accreditation of Healthcare Organizations publication-title: JAMA. doi: 10.1001/jama.284.4.423b – year: 2014 ident: 10.4158/EP14339.RA_bb0265 article-title: Effects of testosterone treatment on bone mineral density in hypogonadal men receiving intrathecal opioids publication-title: Pain Practice – volume: 7 start-page: 901 year: 2006 ident: 10.4158/EP14339.RA_bb0165 article-title: DHEAS deficiency during consumption of sustained-action prescribed opioids: Evidence for opioid-induced inhibition of adrenal androgen production publication-title: J Pain. doi: 10.1016/j.jpain.2006.04.011 – volume: 7 start-page: 269 year: 2010 ident: 10.4158/EP14339.RA_bb0140 article-title: Clomiphene citrate and testosterone gel replacement therapy for male hypogonadism: efficacy and treatment cost publication-title: J Sex Med. doi: 10.1111/j.1743-6109.2009.01454.x – volume: 137 start-page: 631 year: 1997 ident: 10.4158/EP14339.RA_bb0205 article-title: Influence of chronic naltrexone treatment on growth hormone secretion in normal subjects publication-title: Eur J Endocrinol. doi: 10.1530/eje.0.1370631 – volume: 85 start-page: 2215 year: 2000 ident: 10.4158/EP14339.RA_bb0065 article-title: Endocrine consequences of long-term intrathecal administration of opioids publication-title: J Clin Endocrinol Metab. doi: 10.1210/jcem.85.6.6615 – volume: 169 start-page: 725 year: 2013 ident: 10.4158/EP14339.RA_bb0115 article-title: Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes publication-title: Eur J Endocrinol. doi: 10.1530/EJE-13-0321 – reference: - Endocr Pract. 2015 May;21(5):559 – reference: 25716638 - Endocr Pract. 2015 Apr;21(4):450-1 |
| SSID | ssj0020918 |
| Score | 2.2172244 |
| SecondaryResourceType | review_article |
| Snippet | The use of prescription opioids has increased dramatically over the past 20 years. Opioids appear to affect multiple endocrine pathways leading to abnormal... In this article, we review the current data regarding opioid effects on the hypothalamus, pituitary, and bone metabolism. The authors conducted a PubMed search... |
| SourceID | proquest pubmed crossref |
| SourceType | Aggregation Database Index Database Enrichment Source |
| StartPage | 190 |
| SubjectTerms | Analgesics, Opioid - adverse effects Bone and Bones - metabolism Endocrine System Diseases - chemically induced Human Growth Hormone - blood Humans Hypothalamo-Hypophyseal System - drug effects Pituitary-Adrenal System - drug effects Prolactin - blood |
| Title | Opioid Endocrinopathy |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/25536970 https://www.proquest.com/docview/1661322455 https://www.proquest.com/docview/1658706190 |
| Volume | 21 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NT8JAEJ0oJMaL8QO1igSjFw8N_WC77clUgYAJpSGQ4KnZ3e6eTEGB_-8sXSAm6rmTbjr7svNmZvsG4BEpNuOCCbst1WaEmWMzTOBswnkgZO4q5eu_kYdJ0J-232ZkZgpuS3Otcnsmbg7qfC50jbzlYiBB8LUJeV582npqlO6umhEah1DV0mUa1XS2T7gwFoalXqpjh5E7K-VJMWSFrW6KRAFxMo5_BqQ_WOYm2vRO4cTQxGZc7usZHMjiHI6GphF-AbVROhgNOs1u0hm9jgfJKI0n_fcaTHvdyWvfNhMObIHRY2WzPGAqzKVHkSn4knmUEq2G4jlUCcfFbMOhAecRi6THtdCNQI9yQlQYEUZD5l9CpZgX8hqa1OPEyT2ltOIM92XE3ZDqCo9DcAnFLHjafmYmjPy3nkLxkWEaoF2SGZdk49iCh53tohS9-NWqvvVWZoC_zPbbZMH97jFCVvchWCHna21DdHcVqYgFV6WXd8tghuMHiJib_19-C8fIXEh5fboOldXXWt4hO1jxxgYCDai-dJN0_A2HCLUG |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3JTsMwEB2VIgEXxFKgUCAIOHCwmqVukgNCURc1dFXVSuUU7MQ-obbQVoif4hsZN0krJODGOZYtT5793njsGYAblNiMhywkJSGXJcx0wtCBI5TzcigiQ0pLvUZud8qNYelxREcZ-EzfwqhrlemeuNyoo0mozsiLBhIJgq9E6cP0laiqUSq6mpbQiGHRFB_v6LLN7v0q_t9b06zXBpUGSaoKkBB37DlhUZlJJxKmjexsCWbaNlUZSEzdlqFuoMJH155zl7nC5Cq5TIiz4JRKx6XMdpiF_W7AJhKvrpw9e7R28JB7nTg_q04c1xjF6VCRIp1irYfCBHHZ974T4C-qdslu9T3YTWSp5sU42oeMGB_AVjsJvB9Crtvzu35Vq3Wq3Urf73R73qDxlIPhv8z9CLLjyVicgGabnOqRKaXKcMMt4XLDsdWJkk5xCMnycJdOMwiTdOOq6sVLgG6HMkmQmCToe3m4XrWdxkk2fmxVSK0VJAttFqxhkYer1WdcIiruwcZislBtqIrmovTJw3Fs5dUw6FFZZUTo6d-dX8J2Y9BuBS2_0zyDHVRNNL66XYDs_G0hzlGZzPnFEg4aPP83_r4AAe_vUw |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LT8JAEJ4gJMSL8YGKotaoBw8NfbC0PRiDPEJFStNggqe62-6eDKBAjH_NX-csbTEm6o1zN7vZ6bc73-zsfgNwiRSbsohGao2LZQkzTaUYwKmEsXrEY10IU75G7nv17mPtfkRGOfjM3sLIa5XZnrjcqONJJM_Iqzo6EgRfjZCqSK9F-K3O7fRVlRWkZKY1K6eRQKTHP94xfJvduC3811eG0WkPm101rTCgRrh7z1Ua16mwY25Y6KlNTg3LIlKNxNAsEWk6sn0M8xlzqMMNJoVmIpwRI0TYDqGWTU3sdwMKloyK8lC4a3t-sAr30BPbiVqrptqOPkrEUdFh2tW2jzQFURo0frrDPzju0td1tmErJalKI0HVDuT4eBeK_TQNvwelge8O3JbS9lqDZuB6A78x7D6V4HEts9-H_Hgy5oegWAYjWmwIIfVumMkdptuWPF_SCA4haBmus2mGUSo-LmtgvIQYhEiThKlJwqBRhotV22kiufFrq0pmrTBddrPwGyRlOF99xgUjsyB0zCcL2YbI3C4SoTIcJFZeDYPxlVlHvB793_kZFBF74YPr9Y5hEykUSe5xVyA_f1vwE6Qpc3aa4kGB53VD8At-jfTu |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Opioid+Endocrinopathy&rft.jtitle=Endocrine+practice&rft.au=Demarest%2C+Susan+P.&rft.au=Gill%2C+Ranjodh+S.&rft.au=Adler%2C+Robert+A.&rft.date=2015-02-01&rft.issn=1530-891X&rft.volume=21&rft.issue=2&rft.spage=190&rft.epage=199&rft_id=info:doi/10.4158%2FEP14339.RA&rft.externalDBID=n%2Fa&rft.externalDocID=10_4158_EP14339_RA |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1530-891X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1530-891X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1530-891X&client=summon |